Computational pathology-based weakly supervised prediction model for MGMT promoter methylation status in glioblastoma.

He, Yongqi; Duan, Ling; Dong, Gehong; Chen, Feng; Li, Wenbin.

Afiliação

He Y; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Duan L; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Dong G; Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Chen F; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Li W; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Front Neurol ; 15: 1345687, 2024.

Article em En | MEDLINE | ID: mdl-38385046